U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07304063) titled 'Overcoming Barriers to Uptake of Cascade Screening' on Dec. 23.
Brief Summary: Lynch syndrome is a genetic condition that increases cancer risk. The public health impact of genetic testing for disease prevention hinges on cascade screening, which is the systematic identification and testing of blood relatives after a family member has been diagnosed with a genetic condition. Despite its importance in disease prevention, only half of first-degree relatives of individuals with Lynch syndrome undergo cascade screening. To address this gap, the study will pilot test an online version of Let's Talk, a novel intervention designed to suppo...